* Disclaimer: The statements on this site have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, cure, treat, or prevent any disease. Bios Life C™ | Bios Life Complete™
from Rexall - Unicity International
Advanced Cholesterol Control - Naturally Back to Bios Life Slim™ Page Back to Bios Life 2™ Page
Note: Current ingredient listing reflects US formula.
Bios Life C™ Reviews
Bios Life C™( previously known as Bios Life Complete™) is the only fiber and nutrient drink that combines all four of the known natural approaches to lowering harmful cholesterol.
Nearly every adult is concerned with maintaining good heart health. According to the American Heart Association, Cardio Vascular Disease (CVD) is the leading cause of death, and one in three adults will die from CVD. Cholesterol reduction is considered a primary target to reduce the risk for coronary heart disease.
A wide selection of pharmaceuticals are available to reach this goal, the most popular being statins. There is a growing awareness of possible negative side effects of pharmaceuticals, and of statins in particular. Therefore, the public is shifting towards more natural approaches to reduce cholesterol.
1. Helps to block re-absorption of cholesterol in the intestinal tract
2. Helps to block absorption of cholesterol which comes directly from food after digestion
3. Reduces the cholesterol produced by the liver
4. Enhances enzymatic breakdown and removal of LDL (bad) cholesterol
FEATURES AND BENEFITS
Bios Life C™ is quickly becoming the standard in the fight against harmful cholesterol levels.
Often, over a period of time, people taking statins discover that their cholesterol remains at a level higher than they (and their doctors) were hoping to reach. Hope is now available. Talk to your doctor about Bios Life C™ before use if you are taking any cholesterol-lowering medication.
Features and benefits of Bios Life C™:
•Can help reduce LDL cholesterol levels
• Can help to increase HDL cholesterol levels
• Helps manage appetite naturally
Foods containing at least .65 grams per day of plant sterol esters, eaten twice a day with meals for a total daily intake of 1.3 grams may reduce the risk of heart disease. One serving of Bios Life™ Complete contains 0.67 grams of plant sterols.
Cholesterol is a waxy substance found in the bloodstream and in all your body’s cells. It’s normal to have cholesterol, and cholesterol is an important part of a healthy body because it’s used to build new cells, insulate nerves, and produce hormones.
One type of cholesterol is low-density lipoprotein or LDL. High levels of LDL (bad cholesterol) increase the risk of cardiovascular disease. The American Heart Association states that when too much LDL cholesterol circulates in the blood, it can slowly build up in the inner walls of the arteries that feed the heart and brain. LDL cholesterol can form plaque, a thick, hard deposit that can clog those arteries.
The other type of cholesterol is high-density lipoprotein or HDL. Your body makes HDL cholesterol (good cholesterol) for your protection. Studies show that high levels of HDL cholesterol reduce your risk of cardiovascular disease.
Bios Life C™ works effectively to decrease the level of LDL cholesterol while increasing the level of HDL cholesterol through its patented, natural formula. Listed below are the active ingredients responsible for Bios Life C™’s effectiveness: Back to Top
Soluble and Insoluble Fibers
Fibers, in particular of the soluble kind, are well known to reduce LDL-c. [1-16] The American Heart Association therefore advises to include 25 –30 grams of fiber daily in the diet. The mechanism of cholesterol reduction by fiber is through bile-acid sequestration. Typically, fiber is mixed with water, and consumed just before a meal. The gel matrix formed in the digestive tract absorbs bile acids, so that cholesterol re-absorption in the blood is inhibited. The cholesterol reducing effect of fibers has been documented extensively in the literature. The sponsor of this study, Unicity International, has marketed a patented fiber drink (BiosLife 2) that works through bile-acid sequestration.
This sugar cane extract is a poly-alcohol that has been shown to support healthy cholesterol levels through inhibition of HMG CoA reductase. [17-24]
These phytonutrients have similar structures to cholesterol and therefore can competitively inhibit the absorption of cholesterol from the diet.
This flower extract has been linked by internal research to enhancement of cholesterol metabolism. The plant has been used for centuries in the Chinese culture as a tea.
Bios Life C™ is protected by U.S. Patents 6,933,291, 4,883,788, 4,824,672. U.S. and international patents pending.
FAQs Q: How do I know if I have high cholesterol? A: Your cholesterol levels are measured by a simple blood test. A small sample of your blood is analyzed to determine the total cholesterol level, the level of LDL cholesterol, the level of HDL cholesterol, the level of triglycerides, and the ratio of total cholesterol to HDL cholesterol. Even if you don’t currently have a problem with cholesterol, Bios Life™ C may help to prevent future problems.
Q: How much Fiber is in Bios Life™ C? A: The product combines 2.7 grams of soluble fiber with 0.3 grams of insoluble fiber. The product further contains vitamins and minerals, such as chromium. Upon consumption of three packets a day, the fiber amount fills the gap between actual dietary consumption of fiber and the advice of the American Heart Association.
Q: I noticed that Bios Life C™ is sweetened with Sucralose. What is Sucralose and is it safe? A: Sucralose, a low-calorie sweetener, is the sweetening ingredient used worldwide in more than 4,000 food, beverage and nutritional products. The safety of sucralose has been confirmed by leading medical, scientific, and regulatory authorities around the world including; the US Food and Drug Administration (FDA), the Joint (Food and Agriculture Organization/World Health Organization) Expert Committee on Food Additives, European Commission’s Scientific Committee on Food, Health Canada, and Food Standards Australia/New Zealand. For more information about Sucralose visit, www.sucralose.org.
The Physicians‘ Desk Reference® is the nation‘s most trusted source of pharmaceutical and nutritional supplement information and is consulted by more than half a million doctors and pharmacists throughout the US. Ninety percent of health care professionals consider this reference the most important source of reliable information for helping them make the right decision on advising their patients which products they should use.
1. American Heart Association: Heart Disease and Stroke Statistics, 2006 Update.
2. Knopp, R.H., H.R. Superko, M. Davidson, W. Insull, C.A. Dujovne, P.O. Kwiterovich, J.H. Zavoral, K. Graham, R.R. O'Connor, and D.A. Edelman, Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med, 1999. 17(1): p. 18-23.
3. Leinonen, K.S., K.S. Poutanen, and H.M. Mykkanen, Rye bread decreases serum total and LDL cholesterol in men with moderately elevated serum cholesterol. J Nutr, 2000. 130(2): p. 164-70.
4. Riddell, L.J., A. Chisholm, S. Williams, and J.I. Mann, Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr, 2000. 71(6): p. 1448-54.
5. Sprecher, D.L. and G.L. Pearce, Fiber-multivitamin combination therapy: a beneficial influence on low-density lipoprotein and homocysteine. Metabolism, 2002. 51(9): p. 1166-70.
6. Tai, E.S., A.C. Fok, R. Chu, and C.E. Tan, A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia. Ann Acad Med Singapore, 1999. 28(2): p. 209-13.
7. Vuksan, V., D.J. Jenkins, E. Vidgen, T.P. Ransom, M.K. Ng, C.T. Culhane, and D. O'Connor, A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids. Am J Clin Nutr, 1999. 69(2): p. 226-30.
8. Anderson, J.W., L.D. Allgood, J. Turner, P.R. Oeltgen, and B.P. Daggy, Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr, 1999. 70(4): p. 466-73.
9. Anderson, J.W., M.H. Davidson, L. Blonde, W.V. Brown, W.J. Howard, H. Ginsberg, L.D. Allgood, and K.W. Weingand, Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr, 2000. 71(6): p. 1433-8.
10. Birketvedt, G.S., J. Aaseth, J.R. Florholmen, and K. Ryttig, Long-term effect of fibre supplement and reduced energy intake on body weight and blood lipids in overweight subjects. Acta Medica (Hradec Kralove), 2000. 43(4): p. 129-32.
11. Chandalia, M., A. Garg, D. Lutjohann, K. von Bergmann, S.M. Grundy, and L.J. Brinkley, Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med, 2000. 342(19): p. 1392-8.
12. Davidson, M.H. and K.C. Maki, Effects of dietary inulin on serum lipids. J Nutr, 1999. 129(7 Suppl): p. 1474S-7S.
13. Davy, B.M., K.P. Davy, R.C. Ho, S.D. Beske, L.R. Davrath, and C.L. Melby, High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men. Am J Clin Nutr, 2002. 76(2): p. 351-8.
14. Giacco, R., M. Parillo, A.A. Rivellese, G. Lasorella, A. Giacco, L. D'Episcopo, and G. Riccardi, Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care, 2000. 23(10): p. 1461-6.
15. Jenkins, D.J., C.W. Kendall, D.G. Popovich, E. Vidgen, C.C. Mehling, V. Vuksan, T.P. Ransom, A.V. Rao, R. Rosenberg-Zand, N. Tariq, P. Corey, P.J. Jones, M. Raeini, J.A. Story, E.J. Furumoto, D.R. Illingworth, A.S. Pappu, and P.W. Connelly, Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metabolism, 2001. 50(4): p. 494-503.
16. Jenkins, D.J., C.W. Kendall, V. Vuksan, E. Vidgen, T. Parker, D. Faulkner, C.C. Mehling, M. Garsetti, G. Testolin, S.C. Cunnane, M.A. Ryan, and P.N. Corey, Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr, 2002. 75(5): p. 834-9.
17. Kerckhoffs, D.A., G. Hornstra, and R.P. Mensink, Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr, 2003. 78(2): p. 221-7.
18. Castano, G., R. Menendez, R. Mas, A. Amor, J.L. Fernandez, R.L. Gonzalez, M. Lezcay, and E. Alvarez, Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus. Int J Clin Pharmacol Res, 2002. 22(3-4): p. 89-99.
19. Castano, G., R. Mas, J.C. Fernandez, L. Fernandez, J. Illnait, and E. Lopez, Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia. Drugs R D, 2002. 3(3): p. 159-72.
20. Castano, G., R. Mas, L. Fernandez, J. Illnait, R. Gamez, and E. Alvarez, Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study. Int J Clin Pharmacol Res, 2001. 21(1): p. 43-57.
21. Mirkin, A., R. Mas, M. Martinto, R. Boccanera, A. Robertis, R. Poudes, A. Fuster, E. Lastreto, M. Yanez, G. Irico, B. McCook, and A. Farre, Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women. Int J Clin Pharmacol Res, 2001. 21(1): p. 31-41.
22. Castano, G., R. Mas, J.C. Fernandez, J. Illnait, L. Fernandez, and E. Alvarez, Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. J Gerontol A Biol Sci Med Sci, 2001. 56(3): p. M186-92.
23. Crespo, N., J. Illnait, R. Mas, L. Fernandez, J. Fernandez, and G. Castano, Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus. Int J Clin Pharmacol Res, 1999. 19(4): p. 117-27.
24. Mas, R., G. Castano, J. Fernandez, R. Gamez, J. Illnait, L. Fernandez, E. Lopez, M. Mesa, E. Alvarez, and S. Mendoza, Long-term effects of policosanol on obese patients with Type II Hypercholesterolemia. Asia Pac J Clin Nutr, 2004. 13(Suppl): p. S102.
25. Mas, R., G. Castano, J. Fernandez, R.R. Gamez, J. Illnait, L. Fernandez, E. Lopez, M. Mesa, E. Alvarez, and S. Mendoza, Long- term effects of policosanol on older patients with Type 2 diabetes. Asia Pac J Clin Nutr, 2004. 13(Suppl): p. S101.
26. Richelle, M., M. Enslen, C. Hager, M. Groux, I. Tavazzi, J.P. Godin, A. Berger, S. Metairon, S. Quaile, C. Piguet-Welsch, L. Sagalowicz, H. Green, and L.B. Fay, Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans. Am J Clin Nutr, 2004. 80(1): p. 171-7.
27. de Jongh, S., M.N. Vissers, P. Rol, H.D. Bakker, J.J. Kastelein, and E.S. Stroes, Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis, 2003. 26(4): p. 343-51.
28. Ostlund, R.E., Jr., S.B. Racette, and W.F. Stenson, Inhibition of cholesterol absorption by phytosterol-replete wheat germ compared with phytosterol-depleted wheat germ. Am J Clin Nutr, 2003. 77(6): p. 1385-9.
29. Hendriks, H.F., E.J. Brink, G.W. Meijer, H.M. Princen, and F.Y. Ntanios, Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr, 2003. 57(5): p. 681-92.
30. Maki, K.C., F. Shinnick, M.A. Seeley, P.E. Veith, L.C. Quinn, P.J. Hallissey, A. Temer, and M.H. Davidson, Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J Nutr, 2003. 133(3): p. 808-13.
31. Cleghorn, C.L., C.M. Skeaff, J. Mann, and A. Chisholm, Plant sterol-enriched spread enhances the cholesterol-lowering potential of a fat-reduced diet. Eur J Clin Nutr, 2003. 57(1): p. 170-6.
32. Vanstone, C.A., M. Raeini-Sarjaz, W.E. Parsons, and P.J. Jones, Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr, 2002. 76(6): p. 1272-8.
33. Amundsen, A.L., L. Ose, M.S. Nenseter, and F.Y. Ntanios, Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr, 2002. 76(2): p. 338-44.
34. Ostlund, R.E., Jr., S.B. Racette, A. Okeke, and W.F. Stenson, Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr, 2002. 75(6): p. 1000-4.
35. Temme, E.H., P.G. Van Hoydonck, E.G. Schouten, and H. Kesteloot, Effects of a plant sterol-enriched spread on serum lipids and lipoproteins in mildly hypercholesterolaemic subjects. Acta Cardiol, 2002. 57(2): p. 111-5.
36. Judd, J.T., D.J. Baer, S.C. Chen, B.A. Clevidence, R.A. Muesing, M. Kramer, and G.W. Meijer, Plant sterol esters lower plasma lipids and most carotenoids in mildly hypercholesterolemic adults. Lipids, 2002. 37(1): p. 33-42.
37. Mussner, M.J., K.G. Parhofer, K. Von Bergmann, P. Schwandt, U. Broedl, and C. Otto, Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism, 2002. 51(2): p. 189-94.
38. Maki, K.C., M.H. Davidson, D.M. Umporowicz, E.J. Schaefer, M.R. Dicklin, K.A. Ingram, S. Chen, J.R. McNamara, B.W. Gebhart, J.D. Ribaya-Mercado, G. Perrone, S.J. Robins, and W.C. Franke, Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr, 2001. 74(1): p. 33-43.
39. Vissers, M.N., P.L. Zock, G.W. Meijer, and M.B. Katan, Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans. Am J Clin Nutr, 2000. 72(6): p. 1510-5.
40. Hallikainen, M.A., E.S. Sarkkinen, H. Gylling, A.T. Erkkila, and M.I. Uusitupa, Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr, 2000. 54(9): p. 715-25.
41. Jones, P.J., M. Raeini-Sarjaz, F.Y. Ntanios, C.A. Vanstone, J.Y. Feng, and W.E. Parsons, Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res, 2000. 41(5): p. 697-705.
42. Chen, Q., H. De Bont, L. VanderZee, M. Lansink, and K. vanNorren, Cholesterol Lowering Supplement. 2002, N.V. Nutricia: US.
* Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, cure, treat, or prevent any disease.